☰

Puneeth Iyengar, Ph.D. - Publications

Affiliations: 
2005 Yeshiva University, New York, NY, United States 
Area:
Cell Biology, Molecular Biology, Oncology
Tree Info Similar researchers PubMed Report error

69 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, et al. Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement. International Journal of Radiation Oncology, Biology, Physics. 107: 631-640. PMID 32589990 DOI: 10.1016/J.Ijrobp.2020.05.012  0.329
2020 Thor M, Deasy JO, Hu C, Gore E, Bar-Ad V, Robinson C, Wheatley M, Oh JH, Bogart J, Garces YI, Kavadi VS, Narayan S, Iyengar P, Witt JS, Welsh JW, et al. Modeling the impact of cardio-pulmonary irradiation on overall survival in NRG Oncology trial RTOG 0617. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32398326 DOI: 10.1158/1078-0432.Ccr-19-2627  0.338
2020 Khan SA, Gerber DE, Zhu H, Hughes RS, Mannala S, Rashdan S, Dowell J, Westover KD, Saltarski J, Harrah K, Priddy L, Choy H, Timmerman RD, Brekken RA, Sorrelle N, ... Iyengar P, et al. Phase II trial of clinical activity and safety of ceritinib combined with stereotactic ablative radiotherapy (SABR) in lung adenocarcinoma patients. Journal of Clinical Oncology. 38: e21571-e21571. DOI: 10.1200/Jco.2020.38.15_Suppl.E21571  0.346
2019 Bradley JD, Hu C, Komaki RR, Masters GA, Blumenschein GR, Schild SE, Bogart JA, Forster KM, Magliocco AM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn RB, Koprowski CD, et al. Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901162. PMID 31841363 DOI: 10.1200/Jco.19.01162  0.364
2019 Schroeder SR, Leenders M, Iyengar P, de Ruysscher D. Changing equipoise in the landscape of radiation for oligometastatic lung cancer. Translational Lung Cancer Research. 8: S184-S191. PMID 31673523 DOI: 10.21037/Tlcr.2019.07.09  0.338
2019 Bezjak A, Paulus R, Gaspar LE, Timmerman RD, Straube WL, Ryan WF, Garces YI, Pu AT, Singh AK, Videtic GM, McGarry RC, Iyengar P, Pantarotto JR, Urbanic JJ, Sun AY, et al. Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1800622. PMID 30943123 DOI: 10.1200/Jco.18.00622  0.364
2018 Videtic GM, Paulus R, Singh AK, Chang JY, Parker W, Olivier KR, Timmerman RD, Komaki RR, Urbanic JJ, Stephans KL, Yom SS, Robinson CG, Belani CP, Iyengar P, Ajlouni MI, et al. Long term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 30513377 DOI: 10.1016/J.Ijrobp.2018.11.051  0.362
2018 Tumati V, Iyengar P. The current state of oligometastatic and oligoprogressive non-small cell lung cancer. Journal of Thoracic Disease. 10: S2537-S2544. PMID 30206497 DOI: 10.21037/Jtd.2018.07.19  0.339
2018 Arora GK, Gupta A, Narayanan S, Guo T, Iyengar P, Infante RE. Cachexia-associated adipose loss induced by tumor-secreted leukemia inhibitory factor is counterbalanced by decreased leptin. Jci Insight. 3. PMID 30046014 DOI: 10.1172/Jci.Insight.121221  0.316
2018 Kazemzadeh N, Modiri A, Samanta S, Yan Y, Bland R, Rozario T, Wibowo H, Iyengar P, Ahn C, Timmerman R, Sawant A. Virtual Bronchoscopy-Guided Treatment Planning to Map and Mitigate Radiation-Induced Airway Injury in Lung SAbR. International Journal of Radiation Oncology, Biology, Physics. PMID 29891202 DOI: 10.1016/J.Ijrobp.2018.04.060  0.306
2018 Hao H, Zhou Z, Li S, Maquilan G, Folkert MR, Iyengar P, Westover KD, Albuquerque K, Liu F, Choy H, Timmerman RD, Yang L, Wang J. Shell feature: a new radiomics descriptor for predicting distant failure after radiotherapy in non-small cell lung cancer and cervix cancer. Physics in Medicine and Biology. PMID 29616661 DOI: 10.1088/1361-6560/Aabb5E  0.357
2018 Lau SKM, Gannavarapu BS, Carter K, Gao A, Ahn C, Meyer JJ, Sher DJ, Jatoi A, Infante R, Iyengar P. Impact of Socioeconomic Status on Pretreatment Weight Loss and Survival in Non-Small-Cell Lung Cancer. Journal of Oncology Practice. JOP2017025239. PMID 29558251 DOI: 10.1200/Jop.2017.025239  0.304
2018 Deng Y, Wang ZV, Gordillo R, Zhu Y, Ali A, Zhang C, Wang X, Shao M, Zhang Z, Iyengar P, Gupta RK, Horton JD, Hill JA, Scherer PE. Adipocyte Xbp1s overexpression drives uridine production and reduces obesity. Molecular Metabolism. PMID 29551634 DOI: 10.1016/J.Molmet.2018.02.013  0.442
2018 Mendel J, Ward K, Westover K, Timmerman R, Choy H, Iyengar P, Nedzi L, Sher D. Patterns of Failure after 5 Fraction Stereotactic Ablative Radiation Therapy in Early Stage Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e696. DOI: 10.1016/J.Ijrobp.2018.07.1873  0.363
2017 Iyengar P, Wardak Z, Gerber DE, Tumati V, Ahn C, Hughes RS, Dowell JE, Cheedella N, Nedzi L, Westover KD, Pulipparacharuvil S, Choy H, Timmerman RD. Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial. Jama Oncology. e173501. PMID 28973074 DOI: 10.1001/Jamaoncol.2017.3501  0.39
2017 Tumati V, Iyengar P. SABR Rattling With Radiation and Surgery: Paving a Path Toward Refined Treatment of Early-Stage Non-Small-Cell Lung Cancer. Journal of Oncology Practice. 13: 77-78. PMID 28972836 DOI: 10.1200/Jop.2016.020107  0.349
2017 Lau SKM, Iyengar P. Implications of weight loss for cancer patients receiving radiotherapy. Current Opinion in Supportive and Palliative Care. PMID 28914642 DOI: 10.1097/Spc.0000000000000298  0.32
2017 Gore EM, Hu C, Sun AY, Grimm DF, Ramalingam SS, Dunlap NE, Higgins KA, Werner-Wasik M, Allen AM, Iyengar P, Videtic GMM, Hales RK, McGarry RC, Urbanic JJ, Pu AT, et al. Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone To Prophylactic Cranial Irradiation And Consolidative Extra-Cranial Irradiation For Extensive Disease Small Cell Lung Cancer (ED-SCLC): NRG Oncology RTOG 0937. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28648948 DOI: 10.1016/J.Jtho.2017.06.015  0.343
2017 Zhou Z, Folkert M, Iyengar P, Westover K, Zhang Y, Choy H, Timmerman R, Jiang S, Wang J. Multi-objective radiomics model for predicting distant failure in lung SBRT. Physics in Medicine and Biology. 62: 4460-4478. PMID 28480871 DOI: 10.1088/1361-6560/Aa6Ae5  0.3
2017 Chun SG, Hu C, Choy H, Komaki RU, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch W, Galvin JM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn RB, et al. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 35: 56-62. PMID 28034064 DOI: 10.1200/Jco.2016.69.1378  0.365
2017 Lau S, Gannavarapu BS, Carter K, Gao A, Ahn C, Meyer JJ, Sher DJ, Jatoi A, Iyengar P. Impact of socioeconomic status on pretreatment cachexia and survival in non-small cell lung cancer. Journal of Clinical Oncology. 35: 101-101. DOI: 10.1200/Jco.2017.35.31_Suppl.101  0.344
2017 Videtic G, Paulus R, Singh A, Chang J, Parker W, Olivier K, Timmerman R, Komaki R, Urbanic J, Stephans K, Yom S, Robinson C, Belani C, Iyengar P, Ajlouni M, et al. MA 13.08 Long Term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): a Randomized Phase II Study of 2 SBRT Schedules for Lung Cancer Journal of Thoracic Oncology. 12: S1853-S1854. DOI: 10.1016/J.Jtho.2017.09.566  0.304
2017 Iyengar P, Tumati V, Gerber D, Wardak Z, Ahn C, Hughes R, Dowell J, Cheedella N, Nedzi L, Westover K, Pulipparacharuvil S, Choy H, Timmerman R. Consolidative Radiotherapy for Limited Metastatic Non–Small Cell Lung Cancer: A Randomized Phase 2 Trial International Journal of Radiation Oncology*Biology*Physics. 99: 1314. DOI: 10.1016/J.Ijrobp.2017.09.010  0.332
2017 Jin J, Hu C, Wang W, Zhang H, Yu J, Bentzen S, Deasy J, Xiao Y, Schild S, Bogart J, Dobelbower M, Michalski J, Kavadi V, Narayan S, Iyengar P, et al. Effect of PTV and Collimator Margins on Tumor Control for Patients with Stage III Non-small Cell Lung Cancer in NRG Oncology RTOG-0617 International Journal of Radiation Oncology*Biology*Physics. 99: S181-S182. DOI: 10.1016/J.Ijrobp.2017.06.455  0.355
2017 Jin J, Hu C, Xiao Y, Zhang H, Ellsworth S, Schild S, Bogart J, Dobelbower M, Kavadi V, Narayan S, Iyengar P, Robinson C, Brufsky A, Koprowski C, Machtay M, et al. Higher Radiation Dose to Immune System is Correlated With Poorer Survival in Patients With Stage III Non–small Cell Lung Cancer: A Secondary Study of a Phase 3 Cooperative Group Trial (NRG Oncology RTOG 0617) International Journal of Radiation Oncology*Biology*Physics. 99: S151-S152. DOI: 10.1016/J.Ijrobp.2017.06.351  0.364
2016 Zhou Z, Folkert M, Iyengar P, Zhang Y, Wang J. SU-F-R-46: Predicting Distant Failure in Lung SBRT Using Multi-Objective Radiomics Model. Medical Physics. 43: 3383. PMID 28048907 DOI: 10.1118/1.4955817  0.336
2016 Ishihara D, Pop L, Takeshima T, Iyengar P, Hannan R. Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment. Cancer Immunology, Immunotherapy : Cii. PMID 27743027 DOI: 10.1007/S00262-016-1914-6  0.341
2016 Bezjak A, Paulus R, Gaspar LE, Timmerman RD, Straube WL, Ryan WF, Garces Y, Pu AT, Singh AK, Videtic GM, McGarry RC, Iyengar P, Pantarotto JR, Urbanic JJ, Sun A, et al. Efficacy and Toxicity Analysis of NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC). International Journal of Radiation Oncology, Biology, Physics. 96: S8. PMID 27676020 DOI: 10.1016/J.Ijrobp.2016.06.035  0.373
2016 Zhou Z, Folkert MR, Iyengar P, Zhang Y, Westover KD, Wang J. Predicting Distant Failure in Lung Stereotactic Body Radiation Therapy Using Multiobjective Radiomics Model. International Journal of Radiation Oncology, Biology, Physics. 96: S193-S194. PMID 27675757 DOI: 10.1016/J.Ijrobp.2016.06.483  0.318
2016 Gore EM, Hu C, Ad VB, Robinson CG, Wheatley MD, Bogart JA, Garces Y, Kavadi VS, Narayan S, Iyengar P, Witt JS, Welsh JW, Koprowski CD, Larner JM, Bradley JD. Impact of Incidental Cardiac Radiation on Cardiopulmonary Toxicity and Survival for Locally Advanced Non-Small Cell Lung Cancer: Reanalysis of NRG Oncology/RTOG 0617 With Centrally Contoured Cardiac Structures. International Journal of Radiation Oncology, Biology, Physics. 96: S129-S130. PMID 27675596 DOI: 10.1016/J.Ijrobp.2016.06.316  0.33
2016 Giap F, Lau SK, Gannavaparu BS, Iyengar P. Impact of Baseline Cachexia in Non-Small Cell Lung Cancer on Radiation Therapy Utilization and Survival. International Journal of Radiation Oncology, Biology, Physics. 96: E509. PMID 27674880 DOI: 10.1016/J.Ijrobp.2016.06.1904  0.375
2016 Iyengar P, Westover KD, Court LE, Patel MK, Shivnani AT, Saunders MW, Li Y, Chang JY, Gao A, Ahn C, Choy H, Timmerman RD. A Phase III Randomized Study of Image Guided Conventional (60 Gy/30 fx) Versus Accelerated, Hypofractionated (60 Gy/15 fx) Radiation for Poor Performance Status Stage II and III NSCLC Patients-An Interim Analysis. International Journal of Radiation Oncology, Biology, Physics. 96: E451. PMID 27674727 DOI: 10.1016/J.Ijrobp.2016.06.1763  0.303
2016 Zhou Z, Folkert M, Cannon N, Iyengar P, Westover K, Zhang Y, Choy H, Timmerman R, Yan J, Xie XJ, Jiang S, Wang J. Predicting distant failure in early stage NSCLC treated with SBRT using clinical parameters. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27156652 DOI: 10.1016/J.Radonc.2016.04.029  0.334
2016 Iyengar P, Scherer PE. Obesity: Slim without the gym - the magic of chilling out. Nature Reviews. Endocrinology. 12: 252-4. PMID 26915527 DOI: 10.1038/Nrendo.2016.20  0.402
2016 Lau S, Giap F, Gannavarapu BS, Iyengar P. Impact of cachexia at diagnosis on radiotherapy utilization and survival in non-small cell lung cancer. Journal of Clinical Oncology. 34: 133-133. DOI: 10.1200/Jco.2016.34.26_Suppl.133  0.323
2015 Westover KD, Loo BW, Gerber DE, Iyengar P, Choy H, Diehn M, Hughes R, Schiller J, Dowell J, Wardak Z, Sher D, Christie A, Xie XJ, Corona I, Sharma A, et al. Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial. International Journal of Radiation Oncology, Biology, Physics. 93: 72-81. PMID 26279026 DOI: 10.1016/J.Ijrobp.2015.05.004  0.378
2015 Westover KD, Iyengar P, Sharma AN, Timmerman R. SABR for aggressive local therapy of metastatic cancer: A new paradigm for metastatic non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 89: 87-93. PMID 26028304 DOI: 10.1016/J.Lungcan.2015.04.009  0.377
2015 Choy H, Gerber DE, Bradley JD, Iyengar P, Monberg M, Treat J, Govindan R, Koustensis A, Barker S, Obasaju C. Concurrent pemetrexed and radiation therapy in the treatment of patients with inoperable stage III non-small cell lung cancer: a systematic review of completed and ongoing studies. Lung Cancer (Amsterdam, Netherlands). 87: 232-40. PMID 25650301 DOI: 10.1016/J.Lungcan.2014.12.003  0.356
2015 Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. The Lancet. Oncology. 16: 187-99. PMID 25601342 DOI: 10.1016/S1470-2045(14)71207-0  0.35
2015 Cannon NA, Meyer J, Iyengar P, Ahn C, Westover KD, Choy H, Timmerman R. Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 280-5. PMID 25299234 DOI: 10.1097/Jto.0000000000000399  0.333
2015 Chun SG, Iyengar P, Gerber DE, Hogan RN, Timmerman RD. Optic neuropathy and blindness associated with crizotinib for non-small-cell lung cancer with EML4-ALK translocation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: e25-6. PMID 24616318 DOI: 10.1200/Jco.2013.49.1985  0.315
2015 Chun S, Hu C, Choy H, Komaki R, Timmerman R, Schild S, Bogart J, Dobelbower M, Bosch W, Galvin J, Kavadi V, Narayan S, Iyengar P, Robinson C, Wynn R, et al. Comparison of 3-D Conformal and Intensity Modulated Radiation Therapy Outcomes for Locally Advanced Non-Small Cell Lung Cancer in NRG Oncology/RTOG 0617 International Journal of Radiation Oncology*Biology*Physics. 93: S1-S2. DOI: 10.1016/J.Ijrobp.2015.07.010  0.34
2015 Ishihara D, Iyengar P, Meyer J, Timmerman R, Choy H, Hannan R. The combination of radiation therapy and immunotherapy for genitourinary cancer treatment: rationale, current evidence, and prospects Journal of Radiation Oncology. 4: 355-363. DOI: 10.1007/S13566-015-0233-4  0.342
2014 Cannon NA, Iyengar P, Choy H, Timmerman R, Meyer J. Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study. Bmc Cancer. 14: 971. PMID 25518879 DOI: 10.1186/1471-2407-14-971  0.362
2014 Iyengar P, Kavanagh BD, Wardak Z, Smith I, Ahn C, Gerber DE, Dowell J, Hughes R, Abdulrahman R, Camidge DR, Gaspar LE, Doebele RC, Bunn PA, Choy H, Timmerman R. Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3824-30. PMID 25349291 DOI: 10.1200/Jco.2014.56.7412  0.365
2014 Cannon N, Iyengar P, Ahn C, Westover K, Choy H, Timmerman R, Meyer J. Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as Prognostic Factors Following Stereotactic Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S621. DOI: 10.1016/J.Ijrobp.2014.05.1851  0.357
2013 Iyengar P, Westover K, Timmerman RD. Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer. Seminars in Respiratory and Critical Care Medicine. 34: 845-54. PMID 24258574 DOI: 10.1055/S-0033-1358554  0.389
2013 Laine A, Iyengar P, Pandita TK. The role of inflammatory pathways in cancer-associated cachexia and radiation resistance Molecular Cancer Research. 11: 967-972. PMID 23788634 DOI: 10.1158/1541-7786.Mcr-13-0189  0.342
2013 Iyengar P, Gerber DE. Locally advanced lung cancer: an optimal setting for vaccines and other immunotherapies. Cancer Journal (Sudbury, Mass.). 19: 247-62. PMID 23708072 DOI: 10.1097/Ppo.0B013E318292E51A  0.364
2013 Iyengar P, Kavanagh BD, Smith I, Ahn C, Gerber DE, Dowell J, Hughes RS, Abdulrahman R, Camidge DR, Gaspar LE, Doebele RC, Bunn PA, Choy H, Timmerman RD. A phase II trial of second-line erlotinib in combination with stereotactic body radiation therapy (SBRT) for patients with metastatic non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 31: 8074-8074. DOI: 10.1200/Jco.2013.31.15_Suppl.8074  0.352
2013 Cannon N, Iyengar P, Choy H, Timmerman R, Meyer J. Stereotactic Ablative Radiation Therapy for Octogenarians With Lung Cancer: A Single Institution Retrospective Review International Journal of Radiation Oncology*Biology*Physics. 87: S538-S539. DOI: 10.1016/J.Ijrobp.2013.06.1424  0.346
2012 Iyengar P, Timmerman RD. Stereotactic ablative radiotherapy for non-small cell lung cancer: rationale and outcomes. Journal of the National Comprehensive Cancer Network : Jnccn. 10: 1514-20. PMID 23221789 DOI: 10.6004/Jnccn.2012.0157  0.385
2012 Chun SG, Choe KS, Iyengar P, Yordy JS, Timmerman RD. Isolated central nervous system progression on Crizotinib: an Achilles heel of non-small cell lung cancer with EML4-ALK translocation? Cancer Biology & Therapy. 13: 1376-83. PMID 22986231 DOI: 10.4161/Cbt.22255  0.345
2012 Iyengar P, Strom EA, Zhang YJ, Whitman GJ, Smith BD, Woodward WA, Yu TK, Buchholz TA. The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancer. The Oncologist. 17: 1402-8. PMID 22982581 DOI: 10.1634/Theoncologist.2012-0170  0.322
2011 Iyengar P, Choy H. Summary of presentations from the 11th targeted therapies for lung cancer meeting: radiation oncology. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: S1822-4. PMID 22005545 DOI: 10.1097/01.Jto.0000407573.45078.Cf  0.319
2011 Iyengar P, Levy LB, Choi S, Lee AK, Kuban DA. Toxicity associated with postoperative radiation therapy for prostate cancer. American Journal of Clinical Oncology. 34: 611-8. PMID 21150565 DOI: 10.1016/J.Ijrobp.2008.06.1169  0.305
2010 Mazloom A, Fowler N, Medeiros LJ, Iyengar P, Horace P, Dabaja BS. Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the M. D. Anderson Cancer Center experience. Leukemia & Lymphoma. 51: 1217-24. PMID 20443676 DOI: 10.3109/10428191003793358  0.302
2009 Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, Abate N, Zhang BB, Bonaldo P, Chua S, Scherer PE. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Molecular and Cellular Biology. 29: 1575-91. PMID 19114551 DOI: 10.1128/Mcb.01300-08  0.711
2009 Mazloom A, Fowler N, Iyengar P, Dabaja BS. Primary Testicular Diffuse Large B-Cell Lymphoma, M.D. Anderson Cancer Center Experience. Blood. 114: 2697-2697. DOI: 10.1182/Blood.V114.22.2697.2697  0.314
2006 Lara-Lemus R, Liu M, Turner MD, Scherer P, Stenbeck G, Iyengar P, Arvan P. Lumenal protein sorting to the constitutive secretory pathway of a regulated secretory cell. Journal of Cell Science. 119: 1833-42. PMID 16608874 DOI: 10.1242/Jcs.02905  0.428
2005 Pajvani UB, Trujillo ME, Combs TP, Iyengar P, Jelicks L, Roth KA, Kitsis RN, Scherer PE. Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nature Medicine. 11: 797-803. PMID 15965483 DOI: 10.1038/Nm1262  0.663
2005 Iyengar P, Espina V, Williams TW, Lin Y, Berry D, Jelicks LA, Lee H, Temple K, Graves R, Pollard J, Chopra N, Russell RG, Sasisekharan R, Trock BJ, Lippman M, et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. The Journal of Clinical Investigation. 115: 1163-76. PMID 15841211 DOI: 10.1172/Jci23424  0.481
2005 Lin Y, Berg AH, Iyengar P, Lam TK, Giacca A, Combs TP, Rajala MW, Du X, Rollman B, Li W, Hawkins M, Barzilai N, Rhodes CJ, Fantus IG, Brownlee M, et al. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. The Journal of Biological Chemistry. 280: 4617-26. PMID 15536073 DOI: 10.1074/Jbc.M411863200  0.722
2004 Cohen AW, Razani B, Schubert W, Williams TM, Wang XB, Iyengar P, Brasaemle DL, Scherer PE, Lisanti MP. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes. 53: 1261-70. PMID 15111495 DOI: 10.2337/Diabetes.53.5.1261  0.377
2004 Williams TM, Lee H, Cheung MW, Cohen AW, Razani B, Iyengar P, Scherer PE, Pestell RG, Lisanti MP. Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia. The Journal of Biological Chemistry. 279: 24745-56. PMID 15044451 DOI: 10.1074/Jbc.M402064200  0.451
2003 Iyengar P, Scherer PE. Adiponectin/Acrp30, an adipocyte-specific secretory factor: physiological relevance during development. Pediatric Diabetes. 4: 32-7. PMID 14655522 DOI: 10.1034/J.1399-5448.2003.00029.X  0.406
2003 Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C, Lisanti MP, Pestell RG, Scherer PE. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene. 22: 6408-23. PMID 14508521 DOI: 10.1038/Sj.Onc.1206737  0.409
2003 Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P, Jimenez-Chillaron JC, Patti ME, Klein SL, Weinstein RS, Scherer PE. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes. 52: 268-76. PMID 12540596 DOI: 10.2337/Diabetes.52.2.268  0.714
2000 Lee H, Volonte D, Galbiati F, Iyengar P, Lublin DM, Bregman DB, Wilson MT, Campos-Gonzalez R, Bouzahzah B, Pestell RG, Scherer PE, Lisanti MP. Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Molecular Endocrinology (Baltimore, Md.). 14: 1750-75. PMID 11075810 DOI: 10.1210/Mend.14.11.0553  0.336
Show low-probability matches.